Characterization, Evolution and Risk Factors of Diabetes and Prediabetes in a Pediatric Cohort of Renal and Liver Transplant Recipients

Overview

Journal Front Pediatr

Specialty Pediatrics

Date 2023 Feb 24

PMID 36824650

Authors

Sophie Welsch

Virginie Mailleux

Priscilla le Hardy de Beaulieu

Nadejda Ranguelov

Nathalie Godefroid

Annie Robert

Xavier Stephenne

Isabelle Scheers

Raymond Reding

Etienne M Sokal

Philippe A Lysy

Affiliations

Soon will be listed here.

Abstract

Background: Hyperglycemia (HG) and prediabetes are rarely sought in pediatric liver (LT) and renal (RT) transplantation, yet their presence indicates a high risk of diabetes and cardiovascular disease. The objectives of our DIABGRAFT study were to retrospectively (rDIABGRAFT) and longitudinally (pDIABGRAFT) characterize HG and (pre)diabetes in a cohort of children with LT or/and RT.

Methods: We retrospectively analyzed risk factors of HG from 195 children with LT from 2012 to 2019 and twenty children with RT from 2005 to 2019 at Cliniques universitaires Saint-Luc. In addition, we prospectively followed four LT and four RT children to evaluate the evolution of their glucose metabolism.

Results: Our rDIABGRAFT study showed that 25% and 35% of LT and RT children respectively presented transient HG and 20% of RT developed diabetes. The occurrence of HG was associated with the use of glucocorticoids and with acute events as graft rejection and infection. In our pDIABGRAFT cohort, biological markers of diabetes were in the normal range for HbA, fasting glucose and insulin levels. However, oral glucose tolerance test and glucose sensors showed insulin resistance, impaired glucose tolerance and HG in the post-prandial afternoon period.

Conclusion: Our study shows that children with LT and RT were more at risk of developing HG when glucocorticoids were required and that HbA and fasting glucose lack sensitivity for early detection of glucose intolerance. Also, measurement of glycemia immediately after the transplantation and in postprandial period is key to detect dysglycemia since insulin resistance prevailed in our cohort.

Clinicaltrialsgov Id: NCT05464043.

References

Costea R, Maniu I, Dobrota L, Neamtu B . Stress Hyperglycemia as Predictive Factor of Recurrence in Children with Febrile Seizures. Brain Sci. 2020; 10(3). PMC: 7139396. DOI: 10.3390/brainsci10030131. View

Radhakutty A, Burt M . MANAGEMENT OF ENDOCRINE DISEASE: Critical review of the evidence underlying management of glucocorticoid-induced hyperglycaemia. Eur J Endocrinol. 2018; 179(4):R207-R218. DOI: 10.1530/EJE-18-0315. View

Lim W, Lok C, Kim S, Knoll G, Shah B, Naylor K . Impact of Pretransplant and New-Onset Diabetes After Transplantation on the Risk of Major Adverse Cardiovascular Events in Kidney Transplant Recipients: A Population-based Cohort Study. Transplantation. 2021; 105(11):2470-2481. DOI: 10.1097/TP.0000000000003639. View

Cosio F, Kudva Y, van der Velde M, Larson T, Textor S, Griffin M . New onset hyperglycemia and diabetes are associated with increased cardiovascular risk after kidney transplantation. Kidney Int. 2005; 67(6):2415-21. DOI: 10.1111/j.1523-1755.2005.00349.x. View

. 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2022. Diabetes Care. 2021; 45(Suppl 1):S17-S38. DOI: 10.2337/dc22-S002. View

Geer E, Islam J, Buettner C . Mechanisms of glucocorticoid-induced insulin resistance: focus on adipose tissue function and lipid metabolism. Endocrinol Metab Clin North Am. 2014; 43(1):75-102. PMC: 3942672. DOI: 10.1016/j.ecl.2013.10.005. View

Valerio G, Franzese A, Carlin E, Pecile P, Perini R, Tenore A . High prevalence of stress hyperglycaemia in children with febrile seizures and traumatic injuries. Acta Paediatr. 2001; 90(6):618-22. View

Reding R, Gras J, Sokal E, Otte J, Davies H . Steroid-free liver transplantation in children. Lancet. 2003; 362(9401):2068-70. DOI: 10.1016/S0140-6736(03)15104-5. View

Porrini E, Diaz J, Moreso F, Delgado Mallen P, Torres I, Ibernon M . Clinical evolution of post-transplant diabetes mellitus. Nephrol Dial Transplant. 2015; 31(3):495-505. DOI: 10.1093/ndt/gfv368. View

10.

Matthews D, Hosker J, Rudenski A, Naylor B, Treacher D, Turner R . Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985; 28(7):412-9. DOI: 10.1007/BF00280883. View

11.

Al-Uzri A, Stablein D, Cohn R . Posttransplant diabetes mellitus in pediatric renal transplant recipients: a report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS). Transplantation. 2001; 72(6):1020-4. DOI: 10.1097/00007890-200109270-00007. View

12.

Harris P, Taylor R, Thielke R, Payne J, Gonzalez N, Conde J . Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2008; 42(2):377-81. PMC: 2700030. DOI: 10.1016/j.jbi.2008.08.010. View

13.

Cosio F, Pesavento T, Kim S, Osei K, Henry M, Ferguson R . Patient survival after renal transplantation: IV. Impact of post-transplant diabetes. Kidney Int. 2002; 62(4):1440-6. DOI: 10.1111/j.1523-1755.2002.kid582.x. View

14.

. 2. Classification and Diagnosis of Diabetes. Diabetes Care. 2016; 40(Suppl 1):S11-S24. DOI: 10.2337/dc17-S005. View

15.

Gras J, Gerkens S, Beguin C, Janssen M, Smets F, Otte J . Steroid-free, tacrolimus-basiliximab immunosuppression in pediatric liver transplantation: clinical and pharmacoeconomic study in 50 children. Liver Transpl. 2008; 14(4):469-77. DOI: 10.1002/lt.21397. View

16.

Reisaeter A, Hartmann A . Risk factors and incidence of posttransplant diabetes mellitus. Transplant Proc. 2001; 33(5A Suppl):8S-18S. DOI: 10.1016/s0041-1345(01)02229-1. View

17.

Burt M, Roberts G, Aguilar-Loza N, Frith P, Stranks S . Continuous monitoring of circadian glycemic patterns in patients receiving prednisolone for COPD. J Clin Endocrinol Metab. 2011; 96(6):1789-96. DOI: 10.1210/jc.2010-2729. View

18.

Welsch S, Sawadogo K, Brichard B, de Ville de Goyet M, Van Damme A, Boulanger C . Characterization and risk factors of hyperglycaemia during treatment of childhood hematologic malignancies. Diabet Med. 2021; 39(2):e14720. PMC: 9297930. DOI: 10.1111/dme.14720. View

19.

Reding R . Steroid withdrawal in liver transplantation: benefits, risks, and unanswered questions. Transplantation. 2000; 70(3):405-10. DOI: 10.1097/00007890-200008150-00001. View

20.

Cole T, Bellizzi M, Flegal K, Dietz W . Establishing a standard definition for child overweight and obesity worldwide: international survey. BMJ. 2000; 320(7244):1240-3. PMC: 27365. DOI: 10.1136/bmj.320.7244.1240. View